当前位置：首页 > 文献互助 > 互助详情

Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial复制

用户EO9nReo4Hj6s 1小时前 10 10 求助中 帖子自动结束时间: 2025-12-09 00:33:04

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/s1470-2045(25)00523-6复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204525005236复制

其他信息:

出版社: Elsevier BV
作者: Huiping Li; Jieqiong Liu; Quchang Ouyang; Shusen Wang; Yaxin Liu; Yuee Teng; Xiaojia Wang; Jing Cheng; Zhongsheng Tong; Tao Sun; Min Yan; Xin Zhou; Fanfan Li; Jianyun Nie; Zhi-Ming Shao; Changsheng Ye; Yongsheng Wang; Xiaohong Wu; Zhihua Li; Yudong Wu; Huihua Xiong; Hui Li; Lu Gan; Zhaofeng Niu; Juliang Zhang; Qingyuan Zhang; Yueyin Pan; Xinhong Wu; Yi Zhang; Weimin Xie; Yu Xiao; Jinnan Gao; Huadong Zhao; Yongmei Yin; Zhiying Qian; Sanyuan Sun; Hongwei Zhang; Kun Wang; Jinsong Lu; Yong Li; Xinshuai Wang; Xinfeng Yang; Yuting Wang; Quanren Wang; Erwei Song

上一篇：An Aeromonas variant that produces aerolysin promotes susceptibility to ulcerative colitis

下一篇：Intramammary benign vascular proliferative lesions on MRI during neoadjuvant chemoimmunotherapy with camrelizumab in TNBC patients

互助时间线

2025-12-04 00:33:04 [发起求助]

最新发布的求助

Intramammary benign vascular proliferative lesions on MRI during neoadjuvant chemoimmunotherapy with camrelizumab in TNBC patients 46分钟前
Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial 1小时前
An Aeromonas variant that produces aerolysin promotes susceptibility to ulcerative colitis 2小时前
Integrated Neuromorphic Photonic Computing for AI Acceleration: Emerging Devices, Network Architectures, and Future Paradigms 3小时前
Human Neuraminidases: Structures and Stereoselective Inhibitors 5小时前
Discovery of Potent and Balanced Dual RIPK2 and 3 Inhibitors as a New Strategy for the Treatment of Inflammatory Bowel Diseases 5小时前
The role of double-negative B cells in the pathogenesis of systemic lupus erythematosus 5小时前
Discovery of 3g as an Orally Bioavailable, TIR Domain Selective, and Potent MyD88 Inhibitor for the Treatment of Acute Lung Injury 5小时前
Structural control over single-crystalline oxides for heterogeneous catalysis 6小时前
Clinical Use Of Anti-Xa Monitoring In Malignancy-Associated Thrombosis 8小时前
一种含羧甲基壳聚糖的全天然多功能洗手液及其生产方法 8小时前
Penetration and permeation into human skin of fusidic acid in different galenical formulation. 9小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com